Skip to main content

Iridex Corp

IRIX
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0001006045

In the last 90 days, Iridex Corp insiders filed 4 open-market purchases and 0 sales; 29 institutions reported holding it in 13F filings for Q2 2026, worth $2.47M in total; no superinvestor holds it.

Key figures

Insider buysLast 90 days, $15.0K in total
4
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, +5 vs. previous quarter
29
13F valueReported value at the end of Q2 2026
$2.47M
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding IRIX, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding IRIX at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by Iridex Corp insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 16, 2026 (view filing)4:26 PM ETSep 16Same dayDizon Romeo RChief Financial OfficerPPurchase+7.90K$0.63+$4.98K+4.5%185.3K after
Sep 14, 2026 (view filing)11:39 AM ETSep 14Same dayDizon Romeo RChief Financial OfficerPPurchase+2.35K$0.65+$1.53K+1.3%177.4K after
Sep 10, 2026 (view filing)11:53 AM ETSep 10Same dayDizon Romeo RChief Financial OfficerPPurchase+5.10K$0.68+$3.47K+3.0%175.1K after
Aug 24, 2026 (view filing)12:03 PM ETAug 24Same dayDizon Romeo RChief Financial OfficerPPurchase+1.30K$0.7488+$973.44+0.8%164.6K after
Aug 24, 2026 (view filing)12:03 PM ETAug 24Same dayDizon Romeo RChief Financial OfficerPPurchaseCommn Stock+5.37K$0.7499+$4.03K+3.3%170.0K after
Jun 15, 2026 (view filing)Jun 123 daysDizon Romeo RChief Financial OfficerPPurchase+975$1.14+$1.11K+0.7%136.0K after
Jun 12, 2026 (view filing)Jun 111 dayDizon Romeo RChief Financial OfficerPPurchase+1.68K$1.14+$1.91K+1.3%135.0K after
Jun 9, 2026 (view filing)Jun 81 dayDizon Romeo RChief Financial OfficerPPurchase+2.40K$1.12+$2.69K+1.8%133.3K after
Jun 8, 2026 (view filing)Jun 53 daysDizon Romeo RChief Financial OfficerPPurchase+2.52K$1.15+$2.90K+2.0%130.9K after
Jun 3, 2026 (view filing)Jun 3Same dayDizon Romeo RChief Financial OfficerPPurchase+2.40K$1.17+$2.81K+1.9%128.4K after

Top 10 13F holders, Q2 2026

The largest institutional positions in Iridex Corp at the end of Q2 2026; share changes are against Q1 2026.

See all 29 holders
Institutions holding IRIX in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Capital Management LLC514,593$589.2K0.00%00.0%Unchanged
Renaissance Technologies LLC423,542$485.0K0.00%+26,915+6.8%Added
Morgan Stanley305,193$349.4K0.00%+305,193New
Weber Capital Management LLC180,451$206.6K0.18%−79,107−30.5%Reduced
Geode Capital Management, LLC138,960$159.2K0.00%−21,199−13.2%Reduced
Citadel Advisors LLC98,950$113.3K0.00%+38,099+62.6%Added
Perkins Capital Management Inc70,800$81.1K0.06%+15,500+28.0%Added
Vanguard Fiduciary Trust Co60,155$68.9K0.00%00.0%Unchanged
State Street Corp44,718$51.2K0.00%00.0%Unchanged
Goldman Sachs Group Inc40,454$46.3K0.00%+2,833+7.5%Added